Global Medical REIT Inc. (GMRE) Two-Stage Excess Return Model - Discounting Cash Flows
GMRE
Global Medical REIT Inc.
GMRE (NYSE)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Two-Stage Excess Return Model

Used to estimate the value of companies based on two stages of growth. An initial period of high growth, represented by [Sum of discounted excess returns in Growth Stage], followed by a period of stable growth, represented by [Discounted excess return in terminal stage]. Excess Return models are better suited to calculate the intrinsic value of a financial company than an enterprise valuation model (such as the Discounted Free Cash Flow Model).

Read more: GitHub Documentation

Interactive Assumptions

Discount Rate

Discount Rate

Discount Rate = Cost of Equity = Risk Free Rate + Beta * Market Premium

The cost of equity is the theoretical rate of return that an equity investment should generate. It is calculated using the CAPM formula.

Read More

↳ Beta

Beta

Beta is a value that measures the price fluctuations (volatility) of a stock with respect to fluctuations in the overall stock market.

↳ Risk Free Rate

Risk-Free Rate

The risk-free rate represents the interest an investor would expect from an absolutely risk-free investment over a specified period of time. By default, it is equal to the current yield of the U.S. 10 Year Treasury Bond.

↳ Market Premium

Market Premium

Market risk premium represents the excess returns over the risk-free rate that investors expect for taking on the incremental risks connected to the equities market.

High Growth Years

High Growth Years

The estimated number of years during which the company is expected to experience high growth. After this period, the company will transition to a stable growth phase.

Stable Return On Equity

Stable Return on Equity

The stable Return On Equity (ROE) estimated after the last projected period.

Stable Growth In Perpetuity

Stable Growth in Perpetuity

The stable rate at which the company's book value is assumed to grow in perpetuity after the last projected period.

Historical Years

Historical Years

The number of historical years used to calculate averages for historical data.

Results

Estimated Value 13.93 Mil. USD
Book value of equity invested 7.74 USD
Sum of discounted excess returns in Growth Stage 728.8 Thou. USD
Terminal stage EPS 1.17 Mil. USD
Terminal stage Book Value 1.17 Mil. USD
Terminal stage Equity Cost 110.9 Thou. USD
Discounted excess return in terminal stage 13.2 Mil. USD
Excess Returns in the Terminal Stage 20.75 Mil. USD
Terminal Cost of Equity (the discount rate) 9.46%
Terminal year's excess return 1.06 Mil. USD
Average historical Return on Equity 410.3%
Average historical Payout Ratio -3,994%
Payout Ratio in stable stage 95.65%
Yield of the U.S. 10 Year Treasury Bond 4.35%

Historical and Forecasted Data

Monetary values are in USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Beginning Book Value 8.9 8.1 8.1 273.5 6997 121772 1123155
Ending Book Value 8.1 7.74 273.5 6997 121772 1123155 1172013
EPS 0.1 0.052 8.1 273.5 6997 121772 1123155
Return on Equity 1.14% 1.49% 100% 100% 100% 100% 100%
Dividend per Share 0.84 0.78 -257.3 -6450 -107778 -879610 1074298
Payout Ratio 840% 1,500% -3,176% -2,358% -1,540% -722.3% 95.65%
Retained Earnings -0.74 -0.728 265.4 6723 114775 1001383 48857
Equity Cost 0.843 0.767 0.767 25.88 662.2 11524 106295
Cost of Equity 9.46% 9.46% 9.46% 9.46% 9.46% 9.46% 9.46%
Excess Return -0.743 -0.715 7.33 247.6 6334 110247 1016860
Discounted Excess Return
6.7 206.7 4829 76786 647000

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Net Income 0.411 7.94 6.63 20.61 -5.23 -2.07 -20.61 -8.24 13.49 -0.038 -6.35 -1.61
Total Stockholders Equity 403.3 517.4 534.1 583.6 633 622.8 444.8 430.3 269.3 246.3 155 -0.139
Return on Equity 410.3% 1.49% 1.14% 3.26% -0.84% -0.466% -4.79% -3.06% 5.48% -0.025% 4,584% -72.45%
Dividends Paid to Common Shareholders 34.91 52.16 55.39 55.06 54.99 61.85 37 27.09 17.58 15.69 6.89 0.255
Payout Ratio -3,995% 1,500% 840% 365.2% -1,050% -2,982% -177.8% -333.3% 131.1% -42,110% -109% -15.84%
Shares Outstanding 41.43 66.87 65.94 65.55 65.46 60.64 46.26 33.87 21.97 19.62 9.3 0.25
Earnings per Share -0.63 0.052 0.1 0.23 -0.08 -0.034 -0.45 -0.24 0.61 -0.002 -0.68 -6.44
Dividend per Share 0.844 0.78 0.84 0.84 0.84 1.02 0.8 0.8 0.8 0.8 0.741 1.02
Dividend Growth Rate -3.34% -7.14% 0% 0% -17.65% 27.5% 0% 0% 0% 7.96% -27.35%
Book Value 9.81 7.74 8.1 8.9 9.67 10.27 9.62 12.71 12.26 12.56 16.67 -0.554
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us